Skip to content

US · UHS · MEDICAL - CARE FACILITIES

Universal Health Services, Inc. (UHS) intrinsic value and stock valuation

$179.43as of 2026-11-21 · Mkt cap 10.39B

Data updated · price as of 2026-11-21

UndervaluedIC value is 20–50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Universal Health Services, Inc. DCF and intrinsic value

InvestorsCraft values UHS with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from UHS’s statements →

Universal Health Services, Inc. Graham Number

Graham Number: $247.78d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities King of Prussia, PA 19406-0958 uhs.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$17.4B+8.5% 5y CAGRd
20112025
Net income
$1.49B+9.5% 5y CAGRd
20112025
Free cash flow
$849.3M-12.2% 5y CAGRd
20112025
Total equity
$7.41B+3% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$17.4B$15.8B$14.3B$13.4B$12.6B
Operating income$1.99B$1.68B$1.18B$1B$1.36B
Net income$1.49B$1.14B$717.8M$675.6M$991.6M
EPSd$23.1M$16.8M$10.2M$9.15M$11.8M
Operating cash flow$1.86B$2.07B$1.27B$996M$883.7M
Capital expenditure-$-1.02B-$-943.81M-$-743.05M-$-734M-$-855.66M
Free cash flow$849.3M$1.12B$524.7M$262M$28M
Total assets$16B$14.5B$14B$13.5B$13.1B
Total debt$5.51B$4.96B$5.37B$5.27B$4.56B
Net debt$5.37B$4.83B$5.25B$5.17B$4.44B
Total equity$7.41B$6.76B$6.2B$5.97B$6.2B
Cash and short-term investments$137.8M$126M$119.4M$102.8M$115.3M
Income statement
20252024202320222021
Revenue$17.4B$15.8B$14.3B$13.4B$12.6B
Cost of revenue$1.66B$1.59B$1.53B$1.47B$1.43B
Gross profit$15.7B$14.2B$12.7B$11.9B$11.2B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$8.23B$7.67B$7.25B$6.89B$6.28B
Other expenses$5.48B$4.89B$4.33B$4.03B$3.57B
Operating expenses$13.7B$12.6B$11.6B$10.9B$9.85B
Cost and expenses$15.4B$14.1B$13.1B$12.4B$11.3B
Interest income$1.19M$1.43M$570K$380K$1.6M
Interest expense$157.3M$187.5M$207.3M$127.3M$85.3M
Depreciation and amortization$618.7M$584.8M$568M$581.9M$533.2M
Ebitda$2.74B$2.27B$1.72B$1.58B$1.91B
Operating income$1.99B$1.68B$1.18B$1B$1.36B
Total other income/expenses, net-$-21.87M-$-183.88M-$-234.96M-$-137.29M-$-69.78M
Income before tax$1.97B$1.5B$940.4M$866.3M$1.29B
Income tax expense$461M$334.8M$221.1M$209.3M$305.7M
Net income$1.49B$1.14B$717.8M$675.6M$991.6M
Weighted average shares outstanding$63.6M$66.6M$69.3M$73.1M$82.5M
Weighted average diluted shares outstanding$64.5M$67.9M$70.1M$73.8M$83.7M
Balance sheet
20252024202320222021
Cash and short-term investments$137.8M$126M$119.4M$102.8M$115.3M
Net receivables$2.6B$2.18B$2.24B$2.02B$1.75B
Inventory$232.1M$220.9M$217M$218.5M$206.8M
Total current assets$3.41B$2.82B$2.81B$2.54B$2.26B
Property, plant and equipment, net$7.38B$6.99B$6.56B$6.37B$6.24B
Goodwill and intangible assets$4.07B$4.01B$3.93B$3.91B$3.96B
Long-term investments$346.2M$318.7M$0.00$0.00$0.00
Total non-current assets$12.5B$11.7B$11.2B$11B$10.8B
Total assets$16B$14.5B$14B$13.5B$13.1B
Accounts payable$750.1M$632M$614M$636.6M$658.9M
Short-term debt$821.4M$114.7M$198.3M$149.2M$112.9M
Deferred revenue$0.00$0.00$5.38M$2.4M$10K
Total current liabilities$3.24B$2.21B$2.01B$1.91B$1.98B
Long-term debt$4.69B$4.84B$5.17B$5.12B$4.45B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$5.31B$5.5B$5.75B$5.61B$4.91B
Capital lease obligations$426.1M$450.9M$454.2M$463.3M$369.1M
Total liabilities$8.55B$7.71B$7.77B$7.52B$6.9B
Common stock$610K$650K$670K$710K$770K
Retained earnings$7.99B$7.37B$6.8B$5.93B$6.06B
Accumulated other comprehensive income (loss)-$-717.57M-$-706.5M-$-650.6M-$-9.67M$30.3M
Total equity$7.41B$6.76B$6.2B$5.97B$6.2B
Total investments$346.2M$318.7M$0.00$0.00$0.00
Total debt$5.51B$4.96B$5.37B$5.27B$4.56B
Net debt$5.37B$4.83B$5.25B$5.17B$4.44B
Cash flow statement
20252024202320222021
Net income$1.51B$1.16B$717.5M$657M$987.6M
Depreciation and amortization$618.7M$584.8M$568M$581.9M$533.2M
Stock-based compensation$95.7M$99.4M$87.7M$85.4M$73.7M
Change in working capital-$-275.89M$418.8M$17.1M-$-244.35M-$-736.89M
Accounts receivable-$-317.99M$67.4M-$-182.44M-$-258.34M-$-8.87M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$0.00$0.00$0.00$0.00$0.00
Net cash provided by operating activities$1.86B$2.07B$1.27B$996M$883.7M
Investments in property, plant and equipment-$-1.02B-$-943.81M-$-743.05M-$-734M-$-855.66M
Acquisitions, net-$-31.94M-$-18.72M-$-3.73M-$-20.31M-$-105.31M
Net cash used for investing activities-$-1.07B-$-911.11M-$-763.27M-$-647.3M-$-914.47M
Common stock issued$16.7M$15.1M$13.7M$14.1M$13.4M
Common stock repurchased-$-967.95M-$-670.75M-$-547.36M-$-832.92M-$-1.22B
Dividends paid-$-51.27M-$-53.35M-$-55.48M-$-58.45M-$-65.9M
Net cash used for financing activities-$-749.73M-$-1.14B-$-493.94M-$-318.4M-$-1.07B
Net change in cash$46.6M$10.3M$13.6M$21.9M-$-1.1B
Cash at end of period$271.3M$224.8M$214.5M$200.8M$178.9M
Operating cash flow$1.86B$2.07B$1.27B$996M$883.7M
Capital expenditure-$-1.02B-$-943.81M-$-743.05M-$-734M-$-855.66M
Free cash flow$849.3M$1.12B$524.7M$262M$28M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Universal Health Services, Inc.

        Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.

        CEO
        Marc D. Miller
        Employees
        101.5K
        Beta
        1.07

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Universal Health Services, Inc. (UHS)?

        Universal Health Services, Inc. (UHS) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is UHS undervalued?

        UHS trades at a price of $179.43 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.